Skip to content
DataLookout
Menu

FERTICANNCT07148141

Impact of Breast Cancer on Human Folliculogenesis

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

Version history last read from ClinicalTrials.gov on Aug 30, 2026. The record was updated there on Nov 20, 2026; versions filed since then are not listed here yet.

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed
    • Study completion date changed from estimate of Aug 31, 2027 to Aug 31, 2026
  2. Minor Study completion date: Aug 31, 2025 to Aug 31, 2027v2
  3. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Fertility preservation for patients with breast cancer: Altered response to ovarian stimulation and loss of cholesterol homeostasis in ovarian follicles
Timeframe: 65 months

Secondary (8)

Assessment of Anti-Mullerian Hormone levels
Assessment of antral follicle count
Total dose of FSH administered
Number of harvested oocytes
Oocyte maturity
Show 3 moreShow less
Oocyte atresia
Impact of breast cancer on enzymes and regulators of the cholesterol biosynthetic pathway
Quantification of cholesterol and its intermediates in follicular fluids of Breast Cancer patients and Oocytes Donors

Arms and interventions

Breast cancer patients (BC)

Breast cancer subgroups (Triple-negative breast cancer (TN), Hormone-dependent breast cancer (HR+), HER2-amplified breast cancer (HER2+))

Oocyte donors (OD)

Healthy women

Other: Ovarian stimulation

Sites

1 site in 1 country

  • CHU Clermont-FerrandClermont-Ferrand, Auvergne Rhones-Alpes, France